FTC Gives Go-Ahead To $725M Lab Testing Merger

Law360, New York (November 1, 2011, 3:53 PM EDT) -- The Federal Trade Commission on Monday cleared the $725 million sale of a unit of U.S. diagnostics provider Caris Life Sciences to Japan-based laboratory testing company Miraca Holdings Inc.

The agency granted early termination to its antitrust review after the companies’ Oct. 6 announcement of Miraca’s plans to acquire the anatomic pathology business operated by Texas-based Caris Diagnostics Inc., a Caris subsidiary with specialties including gastrointestinal pathology and dermatopathology.

An attorney for Caris declined to comment Tuesday.

Miraca, Japan’s biggest clinical diagnostics and laboratory testing services...
To view the full article, register now.